SXTP 60 Degrees Pharmaceuticals, Inc.

NASDAQ
$1.06

60 Degrees Pharmaceuticals, Inc. (SXTP) is expected to report earnings on November 13, 2026, during market hours. The consensus earnings estimate is a loss of $0.73 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -10.9% since its last earnings release on August 14, 2026.

60 Degrees Pharmaceuticals Missed Consensus Estimates
Friday, August 14, 2026 · 3:47 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 13
Friday · 8:40 AM ET
Earnings Whisper
-
vs ($0.73)
Rev est $300K
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $1.10

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About 60 Degrees Pharmaceuticals, Inc.

60 Degrees Pharmaceuticals Inc. specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. 60 Degrees Pharmaceuticals Inc. is based in WASHINGTON.

Sector

Healthcare

Industry

Drug Manufacturers/Other